273 results
8-K
EX-3.1
LXRX
Lexicon Pharmaceuticals Inc
10 May 24
Unregistered Sales of Equity Securities
4:15pm
under the Corporation’s equity incentive plans or any other plan or agreement approved by the Board of Directors, to pay the applicable exercise price
8-K
EX-1.1
w03dvbaoteaf680g5
29 Dec 23
Entry into a Material Definitive Agreement
5:29pm
424B5
8d45k7vmlsp
29 Dec 23
Prospectus supplement for primary offering
5:27pm
S-8
EX-23.1
gnjpkt0l2
4 Aug 23
Registration of securities for employees
7:09am
S-8
y98lv9 9dq
4 Aug 23
Registration of securities for employees
7:09am
S-8
nqodyur
4 Aug 23
Registration of securities for employees
7:09am
S-8
EX-5.1
unpckkgk3vncsjw63zj3
4 Aug 23
Registration of securities for employees
7:09am
8-K
4mrxo909zp8t2m 0n
31 Jul 23
Lexicon Elects Diane E. Sullivan to Board of Directors
4:02pm
8-K
EX-1.1
dnpr 64c8dxu
2 Jun 23
Lexicon Announces Pricing of $125 Million Public Offering and Concurrent Private Placement
4:31pm
424B5
qxxge78s
1 Jun 23
Prospectus supplement for primary offering
9:08pm